Showing results (351-360 of 497) with videos related to

Sort By:
Pageof 50
Annals of Nuclear Medicine|March 17, 2019
18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studiesSara Sheikhbahaei, Krystyna M Jones, Rudolf A Werner, et al.
Clinical Nuclear Medicine|April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and TherapySebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Clinical Nuclear Medicine|May 5, 2025
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple MyelomaNiklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Oncotarget|June 4, 2016
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathyRudolf A Werner, Seval Beykan, Takahiro Higuchi, et al.
Journal of the American Heart Association|March 3, 2025
Illuminating Cardiac Remodeling: Insights From [18F]-Fluorodeoxyglucose Positron Emission Tomography Imaging in Plakoglobin-Associated Arrhythmogenic CardiomyopathyTatjana Williams, Regina Groß, Anahi-Paula Arias-Loza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2012
Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in ratsHossam M Sherif, Antti Saraste, Stephan G Nekolla, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
Comparison of 18F-Labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion ImagingDong-Yeon Kim, Hyeon Sik Kim, Sybille Reder, et al.
Clinical Nuclear Medicine|November 10, 2022
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System TumorsAleksander Kosmala, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2012
PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathyPaco E Bravo, Aurélio Pinheiro, Takahiro Higuchi, et al.
Pageof 50